Drug maker Novartis AG (NOVN.CH) is in advanced talks to acquire MorphoSys AG (MOR.DE), two people familiar with the matter told Reuters on Monday.
The sources added that there is no certainty that negotiations on the deal will be successful and asked to remain anonymous as the matter is confidential. They declined to provide any information on the acquisition price.
MorphoSys shares are currently gaining nearly 37%.

Source: xStation
US Open: Nasdaq 100 gains 1% 🔼 Software stocks decline, JP Morgan rises after earnings
Software stocks slide on enterprise spending concerns 🚩 Microsoft drops 3%
Goldman Sachs Wins, Citigroup Loses: Why the Market Viewed Two Strong Earnings Reports Differently
Worse than the Dot-com bubble: IBM stock crash